Contribute Try STAT+ Today

Good morning, everyone, and how are you today? We are doing just fine, thank you, despite the gloomy and soggy skies hovering over the Pharmalot campus. After all, the Morning Mayor once told us that “every new day should be unwrapped like a precious gift.” So while you tug on the ribbon, we will brew another cup of stimulation and forage for items of interest. Speaking of which, here are a few tidbits to help you along. We hope your day is productive and peaceful. As always, do keep in touch and stay safe — wear a mask. …

President Trump is lashing out at the Food and Drug Administration after Pfizer (PFE) reported its Covid-19 vaccine is more than 90% effective, The Washington Post reports. Trump is convinced the timing — six days after Election Day — proves the “medical deep state” deliberately tried to sabotage his electoral prospects by delaying the results. Shortly after Trump heard the news, he demanded Health and Human Services Secretary Alex Azar “get to the bottom” of what happened with Pfizer.

Unlock this article by subscribing to STAT+ and enjoy your first 30 days free!

GET STARTED

What is it?

STAT+ is STAT's premium subscription service for in-depth biotech, pharma, policy, and life science coverage and analysis. Our award-winning team covers news on Wall Street, policy developments in Washington, early science breakthroughs and clinical trial results, and health care disruption in Silicon Valley and beyond.

What's included?

  • Daily reporting and analysis
  • The most comprehensive industry coverage from a powerhouse team of reporters
  • Subscriber-only newsletters
  • Daily newsletters to brief you on the most important industry news of the day
  • STAT+ Conversations
  • Weekly opportunities to engage with our reporters and leading industry experts in live video conversations
  • Exclusive industry events
  • Premium access to subscriber-only networking events around the country
  • The best reporters in the industry
  • The most trusted and well-connected newsroom in the health care industry
  • And much more
  • Exclusive interviews with industry leaders, profiles, and premium tools, like our CRISPR Trackr.

Your daily dose of news in health and medicine

Privacy Policy